You just read:

Data Presented at Society for Neuro-Oncology Annual Meeting Demonstrate Tocagen's Toca 511 Gene Therapy with Toca FC was Well Tolerated and Showed Antitumor Activity in Patients with High Grade Glioma

News provided by

Tocagen Inc.

Nov 26, 2013, 08:00 ET